Cent Secures $15M Series A Funding to Scale AI-Powered Preventive Healthcare Platform

Cent Closes $15 Million Series A Funding Round

Cent, the preventive health intelligence startup, secured $15 million in Series A funding on October 27, with the round co-led by Blume Ventures and existing investor South Park Commons1

1

2

2

. The funding round, which includes both equity and debt, attracted participation from notable individual investors including former Vodafone CEO Arun Sarin and former OpenAI B2B CTO Srinivas Narayanan. This investment marks a significant milestone for the healthtech startup founded earlier in 2025 by Shashank ND, founder of Practo and OneFlow Holdings, along with Anshul Khandelwal, former Chief Marketing Officer of Ola Electric, and Arpit Garg, former Product Head at Lenskart1

1

.

Building an AI-Led Preventive Healthcare Platform

Cent positions itself as a transformative force in India's healthcare landscape, which traditionally focuses on treating illness rather than preventing it. The AI-powered preventive healthcare platform combines specialized hardware, AI-driven diagnostics, and bioinformatics to identify potential health risks before symptoms appear1

1

. "India's healthcare system is still built to treat illness, not to find it early. We believe the next shift is preventive care that is precise and accessible at scale," said Anshul Khandelwal, co-founder of Cent1

1

. The startup has completed 10,000 preventive whole-body scans across Bengaluru, Mumbai, and Delhi NCR since inception, with an ambitious target to scale to 1 crore scans by 20352

2

.

Cent Check: Comprehensive Health Screening for Asymptomatic Patients

The flagship offering, Cent Check, screens asymptomatic patients for over 300 conditions including cardiac disease, cancer, and neurological disorders through a single visit lasting approximately two hours2

2

. The comprehensive screening combines full-body MRI, low-dose CT, DEXA scans, ECG, echocardiography, and more than 100 biomarkers following the company's proprietary CCNM™ Protocol1

1

2

2

. Priced at ₹27,500, the service positions itself as an alternative to conventional preventive health checkups that largely rely on blood tests and limited imaging2

2

. The AI system consolidates results to generate organ-level risk assessments, which specialist doctors review before providing members with a doctor-led health plan and year-long support1

1

.

Early Detection Reveals Critical Health Findings

The early detection of health risks through Cent's platform has already yielded significant results. Among members who felt healthy when they arrived for screening, one in four had a finding that warranted action, while one in 40 required immediate medical attention1

1

. The findings included early-stage tumors, significantly narrowed arteries, and aneurysms, demonstrating the critical value of comprehensive preventive screening. "Our first 10,000 scans have shown us how much that shift is needed," Khandelwal noted1

1

. This data underscores the gap in India's current healthcare approach and validates Cent's mission to shift from reactive treatment to proactive prevention.

Medsee Acquisition Strengthens AI-Powered Radiology Reporting

Alongside the Series A funding announcement, Cent revealed its acquisition of Medsee, an AI-powered radiology reporting workflow platform founded by Chitra Singh1

1

2

2

. The platform drafts structured reports and highlights findings for qualified radiologists to review, enabling faster and more consistent reporting as scan volumes increase1

1

. This strategic acquisition strengthens Cent's technological capabilities and supports its goal of scaling operations while maintaining diagnostic accuracy. The integration of AI-assisted imaging also helps reduce MRI scan times, making the process more efficient for both patients and healthcare providers2

2

.

Investment to Fuel R&D and Team Expansion

The fresh capital will be deployed to strengthen Cent's research and development function, with particular focus on expanding its AI, engineering, and clinical teams1

1

2

2

. The investment enables the company to enhance its capabilities in AI, medical imaging, and clinical research while building preventive healthcare infrastructure in India to serve global needs1

1

. Blume Ventures co-founder and managing partner Karthik Reddy stated that the firm backed Cent's ambition to improve diagnostic accuracy for cancers and other conditions, with plans to eventually expand its approach beyond India1

1

. The startup plans to use data generated through its scans to establish health baselines for asymptomatic Indians, train models to identify disease risks earlier, and support clinical research2

2

.